PKC-θ Modulates the Strength of T Cell Responses by Targeting Cbl-b for Ubiquitination and Degradation

被引:64
作者
Gruber, Thomas [1 ]
Hermann-Kleiter, Natascha [1 ]
Hinterleitner, Reinhard [1 ]
Fresser, Friedrich [1 ]
Schneider, Rainer [2 ]
Gastl, Guenther [3 ]
Penninger, Josef M. [4 ]
Baier, Gottfried [1 ]
机构
[1] Med Univ Innsbruck, Dept Med Genet Clin & Mol Pharmacol, A-6020 Innsbruck, Austria
[2] Univ Innsbruck, Inst Biochem, A-6020 Innsbruck, Austria
[3] Med Univ Innsbruck, Lab Tumor Immunol, Dept Hematol & Oncol, A-6020 Innsbruck, Austria
[4] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria
基金
奥地利科学基金会;
关键词
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IN-VIVO; LYMPHOCYTE-ACTIVATION; NEGATIVE REGULATION; DEFICIENT MICE; CUTTING EDGE; COSTIMULATION; RESISTANCE; STIMULATION; PROTEOLYSIS;
D O I
10.1126/scisignal.2000046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The E3 ubiquitin ligase Casitas B-lineage lymphoma (Cbl-b) is central to antigen-induced immune tolerance and regulates the CD28 dependence of T cell activation. Cbl-b undergoes ubiquitination and proteasomal degradation after adequate costimulation of T cells; however, the mechanism involved is unknown. Here, we identified protein kinase C-theta (PKC-theta) as the critical intermediary for the inactivation of Cbl-b in response to costimulation of T cells through CD28. PKC-theta associated with Cbl-b on stimulation of the T cell receptor. After costimulation of T cells through CD28, Cbl-b was ubiquitinated and degraded through a mechanism that depended on the kinase activity of PKC-theta. Consistent with this mechanism, the impaired responses of PKC theta-deficient T cells were at least partially restored by the concomitant genetic loss of cblb. Thus, our data establish a nonredundant antagonism between PKC-theta and Cbl-b that regulates T cell activation responses.
引用
收藏
页数:8
相关论文
共 40 条
[1]   Positive feedback regulation of PLCγ1/Ca2+ signaling by PKCθ in restimulated T cells via a Tec kinase-dependent pathway [J].
Altman, A ;
Kaminski, S ;
Busuttil, V ;
Droin, N ;
Hu, JR ;
Tadevosyan, Y ;
Hipskind, RA ;
Villalba, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (07) :2001-2011
[2]   Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b [J].
Bachmaier, K ;
Krawczyk, C ;
Kozieradzki, I ;
Kong, YY ;
Sasaki, T ;
Oliveira-dos-Santos, A ;
Mariathasan, S ;
Bouchard, D ;
Wakeham, A ;
Itie, A ;
Le, J ;
Ohashi, PS ;
Sarosi, I ;
Nishina, H ;
Lipkowitz, S ;
Penninger, JM .
NATURE, 2000, 403 (6766) :211-216
[4]  
BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842
[5]   PKCθ signals activation versus tolerance in vivo [J].
Berg-Brown, NN ;
Gronski, MA ;
Jones, RG ;
Elford, AK ;
Deenick, EK ;
Odermatt, B ;
Littman, DR ;
Ohashi, PS .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (06) :743-752
[6]   Nedd4 Controls Animal Growth by Regulating IGF-1 Signaling [J].
Cao, Xiao R. ;
Lill, Nancy L. ;
Boase, Natasha ;
Shi, Peijun P. ;
Croucher, David R. ;
Shan, Hongbo ;
Qu, Jing ;
Sweezer, Eileen M. ;
Place, Trenton ;
Kirby, Patricia A. ;
Daly, Roger J. ;
Kumar, Sharad ;
Yang, Baoli .
SCIENCE SIGNALING, 2008, 1 (38)
[7]   Ablation of Cbl-b provides protection against transplanted and spontaneous tumors [J].
Chiang, Jeffrey Y. ;
Jang, Ihn Kyung ;
Hodes, Richard ;
Gu, Hua .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (04) :1029-1036
[8]   Cbl-b regulates the CD28 dependence of T-cell activation [J].
Chiang, YPJ ;
Kole, HK ;
Brown, K ;
Naramura, M ;
Fukuhara, S ;
Hu, RJ ;
Jang, IK ;
Gutkind, JS ;
Shevach, E ;
Gu, H .
NATURE, 2000, 403 (6766) :216-220
[9]  
Dalgaard P., 2002, INTRO STAT R
[10]   Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells [J].
Fang, DY ;
Liu, YC .
NATURE IMMUNOLOGY, 2001, 2 (09) :870-875